                         SEQUENCE LISTING

<110>  SRI International
 
<120>  TARGETED ANTIGEN DELIVERY SYSTEM AND USES THEREOF

<130>  37794.0097P1

<150>  63081178
<151>  2020-09-21

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; targeting sequence

<400>  1

Leu Gln Trp Arg Arg Asn Phe Gly Val Trp Ala Arg Tyr Arg Leu 
1               5                   10                  15  


<210>  2
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; targeting sequence

<400>  2

Leu Gln Trp Arg Arg Asp Asp Asn Val His Asn Phe Gly Val Trp Ala 
1               5                   10                  15      


Arg Tyr Arg Leu 
            20  


<210>  3
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; targeting peptide


<220>
<221>  misc
<222>  (15)..(16)
<223>  PEG11 linker between L and K

<220>
<221>  misc
<222>  (16)..(17)
<223>  PEG11 linker between K and L

<400>  3

Leu Gln Trp Arg Arg Asn Phe Gly Val Trp Ala Arg Tyr Arg Leu Lys 
1               5                   10                  15      


Leu Arg Tyr Arg Ala Trp Val Gly Phe Asn Arg Arg Trp Gln Leu 
            20                  25                  30      


<210>  4
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; targeting peptide


<220>
<221>  misc
<222>  (15)..(16)
<223>  PEG11 linker between L and K

<220>
<221>  misc
<222>  (16)..(17)
<223>  PEG11 linker between K and L

<220>
<221>  misc
<222>  (16)..(16)
<223>  Lys branchpoint can have a tag or reactive moiety for conjugation

<400>  4

Leu Gln Trp Arg Arg Asn Phe Gly Val Trp Ala Arg Tyr Arg Leu Lys 
1               5                   10                  15      


Leu Arg Tyr Arg Ala Trp Val Gly Phe Asn Arg Arg Trp Gln Leu 
            20                  25                  30      


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; H250 peptide

<400>  5

Ser Met Tyr Arg Val Phe Glu Val Gly Val 
1               5                   10  


<210>  6
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; C166 peptide

<400>  6

Ser Leu Trp Gly Ser Leu Leu Met Leu 
1               5                   


<210>  7
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; H38 peptide

<400>  7

Leu Leu Ala Val Ile Phe Val Met Phe Leu 
1               5                   10  


<210>  8
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; H516 peptide

<400>  8

Ile Leu Pro Gly Gln Asp Leu Gln Tyr Val 
1               5                   10  


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; H3L peptide

<400>  9

Ser Leu Ser Ala Tyr Ile Ile Arg Val 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; E2L peptide

<400>  10

Lys Ile Asp Tyr Tyr Ile Pro Tyr Val 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct; Q1L peptide

<400>  11

Gly Leu Asn Asp Tyr Leu His Ser Val 
1               5                   


<210>  12
<211>  40
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic construct; primer

<400>  12
agaggatcca ccggtcgcca ccatggaaga tgccaaaaac                             40


<210>  13
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic construct; primer

<400>  13
atagctcgag ttagacgttg atcctggcgc                                        30


